Article
08 Apr 2025
Commercialization Of Ustekinumab And Golimumab Biosimilars
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
30 Dec 2024
Bio-Thera Solutions Expands Partnership With SteinCares To Market Two Biosimilars In LATAM
Article
18 Nov 2024
Celltrion Launches STEQEYMA (Ustekinumab) In Germany And The Netherlands
Article
09 Sep 2024
PTAB Institutes Sarepta's IPR
Article
02 Jul 2024
Biogen's TOFIDENCE (Tocilizumab) Approved In The EU
Article
05 Jun 2024
USPTO Proposed Rulemaking Regarding Terminal Disclaimers
Article
24 Apr 2024
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation
Article
21 Mar 2024
Celltrion Submits BLA For Omalizumab Biosimilar
Article
16 Jan 2024
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
Article
30 Sep 2023
FDA Releases Draft Labeling Guidance For Biosimilar Products